Analyst IMS Investment Management Services’s AbbVie ABBV Stock Holding History

Analyst IMS Investment Management Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$974K	Sell	3,869 -1,276	-25%	-$275K	0.02%	100
2026 Q1	$1.12M	Buy	5,145 +364	+8%	+$80.7K	0.03%	81
2025 Q4	$1.09M	Buy	4,781 +2,020	+73%	+$460K	0.03%	78
2025 Q3	$639K	Sell	2,761 -424	-13%	-$86.3K	0.02%	102
2025 Q2	$591K	Sell	3,185 -2,409	-43%	-$448K	0.02%	106
2025 Q1	$1.17M	Buy	5,594 +2,286	+69%	+$444K	0.05%	78
2024 Q4	$588K	Sell	3,308 -1,697	-34%	-$312K	0.02%	101
2024 Q3	$988K	Buy	5,005 +2,018	+68%	+$377K	0.04%	79
2024 Q2	$512K	Buy	+2,987	New	+$495K	0.02%	99

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Analyst IMS Investment Management Services's ABBV Position: Q2 2026 in Review

Analyst IMS Investment Management Services reduced its AbbVie (ABBV) stake by 25% in Q2 2026, selling an estimated $275K and leaving 3,869 shares worth $974K. The position accounts for 0.02% of the portfolio, ranked #100.

Analyst IMS Investment Management Services first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.17M in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Analyst IMS Investment Management Services held 3,869 shares of AbbVie worth $974K as of Q2 2026.
Analyst IMS Investment Management Services sold 1,276 AbbVie shares in Q2 2026, an estimated $275K.
AbbVie made up 0.02% of Analyst IMS Investment Management Services's portfolio in Q2 2026, its #100 holding.
Analyst IMS Investment Management Services first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
Analyst IMS Investment Management Services's AbbVie position peaked at $1.17M in Q1 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.